Genomic Alterations and MYD88(MUT) Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to Ibrutinib

Jiang, SY; Qin, Y; Gui, L; Liu, P; Jiang, HX; Liu, B; Yang, JL; Yang, S; He, XH; Zhou, SY; Du, XH; Yi, YT; Lin, J; Shi, YK

Shi, YK (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Dept Med Oncol, Natl Canc Ctr,Canc Hosp,Beijing Key Lab Clin Stud, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China.

TARGETED ONCOLOGY, 2020; 15 (2): 221

Abstract

Background Diffuse large B-cell lymphoma (DLBCL) is a clinically heterogeneous malignancy. Following front-line immunochemotherapy, 30-40% of DLBCL pa......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索